Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study

Detalles Bibliográficos
Autores principales: Awad, Mark M., Le Bruchec, Yvan, Lu, Brian, Ye, Jason, Miller, Julie Ann, Lizotte, Patrick H., Cavanaugh, Megan E., Rode, Amanda J., Dumitru, Calin Dan, Spira, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210944/
https://www.ncbi.nlm.nih.gov/pubmed/35747830
http://dx.doi.org/10.3389/fonc.2022.889996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210944/
https://www.ncbi.nlm.nih.gov/pubmed/35747830
http://dx.doi.org/10.3389/fonc.2022.889996

Ejemplares similares